parallax background

ADDRESSING PRIORITY HEALTH ISSUES THROUGH EDUCATION, RESEARCH AND SERVICE

The UCT Lung Institute


The University of Cape Town Lung Institute (UCTLI) is a private company wholly owned by the University of Cape Town. Our mandate is to Address Priority Health Issues through Education, Research and Service. Our building is located on Hospital Bend adjacent to the UCT Faculty of Health Sciences. We provide clinical services and conduct research in the fields of Respiratory Medicine, Tuberculosis, COVID-19 and Allergy. Our services include evaluation of new TB treatments and investigating new TB diagnostics in adults and children. We also conduct COVID-19 vaccine and COVID-19 treatment research. Our team offers a limited private practice service in Allergy and Respiratory Medicine. We work closely with the Faculty of Health Sciences and use our extended platform to facilitate student and postgraduate training. The UCTLI collaborates widely with higher training institutions and research entities elsewhere in South Africa, on the African continent and abroad.


                   

Latest news

11th February 2025

Tuberculosis Drug Resistance: The Alarming Surge of Bedaquiline Resistance in South Africa

Prof Keertan Dheda, Professor of Respiratory Medicine at the University of Cape Town and Professor of Mycobacteriology and Global Health at LSHTM, is a world leader in the field of TB diagnosis and transmission. In this interview with Dr Richard Wall, he discusses the impending threat of bedaquiline-resistant TB in South Africa and the steps required to minimise its spread.